Annora Pharma Profile
Key Indicators
- Authorised Capital ₹ 316.00 Cr
as on 16-11-2024
- Paid Up Capital ₹ 286.00 Cr
as on 16-11-2024
- Company Age 9 Year, 24 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 396.32 Cr
as on 16-11-2024
- Revenue 31.62%
(FY 2023)
- Profit 221.74%
(FY 2023)
- Ebitda 73.59%
(FY 2023)
- Net Worth 31.20%
(FY 2023)
- Total Assets 18.85%
(FY 2023)
About Annora Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 316.00 Cr and a paid-up capital of Rs 286.00 Cr.
The company currently has active open charges totaling ₹396.32 Cr.
The Key Managerial Personnel (KMP) at Annora Pharma Private Limited India is Parul Khandelwal as COMPANY SECRETARY. Chandra Tumuluru, Palleswara Govada, Govindaraju Bhavani, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24100TG2015PTC101939
- Company No.
101939
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Nov 2015
- Date of AGM
14 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Medak, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Annora Pharma Private Limited offer?
Annora Pharma Private Limited offers a wide range of products and services, including Software Development Services, Java Software Development Service.
Who are the key members and board of directors at Annora Pharma?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Parul Khandelwal  | Company Secretary | 30-Jun-2022 | Current |
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Chandra Tumuluru | Director | 26-Nov-2015 | Current |
| Palleswara Govada | Director | 26-Nov-2015 | Current |
| Govindaraju Bhavani | Director | 30-Jun-2022 | Current |
| Mahesh Hassan | Director | 30-Mar-2018 | Current |
| Bhaskarreddy Pabbatireddy | Director | 05-Mar-2020 | Current |
Financial Performance and Corporate Structure Insights of Annora Pharma.
Annora Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 31.62% increase. The company also saw a substantial improvement in profitability, with a 221.74% increase in profit. The company's net worth Soared by an impressive increase of 31.2%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Annora Pharma?
In 2023, Annora Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Hetero Biopharma LimitedActive 8 years 3 monthsChandra Tumuluru and Govindaraju Bhavani are mutual person
- Hetero Plasma Sciences Private LimitedActive 1 year 4 months
Bhaskarreddy Pabbatireddy is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 20 Dec 2023 | ₹160.00 Cr | Open |
Others Creation Date: 22 Mar 2023 | ₹0.90 M | Open |
Others Creation Date: 10 Sep 2022 | ₹0.90 M | Open |
How Many Employees Work at Annora Pharma?
Unlock and access historical data on people associated with Annora Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Annora Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Annora Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
